Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCL-2--general considerations.

E Moldoveanu1, I Stoian, L Voinea

  • 1Victor Babes Institute, Bucharest, Romania.

Haematologia
|March 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis.

European review for medical and pharmacological sciences·2024
Same author

Serum biomarkers predictive of cirrhosis in alcoholic liver disease as an alternative to ARFI-SW elastography.

European review for medical and pharmacological sciences·2023
Same author

Corneal biomechanical properties in myopic and emmetropic children.

European review for medical and pharmacological sciences·2023
Same author

SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.

Acta endocrinologica (Bucharest, Romania : 2005)·2019
Same author

Oxidative stress in androgenetic alopecia.

Journal of medicine and life·2016
Same author

Lipoprotein-associated phospholipase A2, myeloperoxidase and vascular endothelial growth factor - predictors of high vascular risk in respiratory bacterial infections.

Journal of medicine and life·2016
Same journal

The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.

Haematologia·2003
Same journal

Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

Haematologia·2003
Same journal

Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.

Haematologia·2003
Same journal

Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

Haematologia·2003
Same journal

Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.

Haematologia·2003
Same journal

Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.

Haematologia·2003
See all related articles

The BCL-2 oncoprotein regulates programmed cell death (apoptosis). This review discusses its cellular location, interactions with other oncoproteins, antioxidant roles, and links to disease.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The BCL-2 protein is a key oncoprotein involved in apoptosis regulation.
  • Understanding BCL-2's function is crucial for cancer research and therapy.

Purpose of the Study:

  • To review the role of BCL-2 in apoptosis.
  • To discuss its intracellular localization and interactions with other oncoproteins.
  • To explore its antioxidant functions and pathological implications.

Main Methods:

  • Literature review and synthesis of existing research on BCL-2.
  • Analysis of studies on protein localization and interactions.
  • Examination of data regarding antioxidant activity and disease association.

Related Experiment Videos

Main Results:

  • BCL-2 plays a critical role in inhibiting apoptosis.
  • Its localization and interactions influence cell survival pathways.
  • Evidence suggests an antioxidant function contributing to its oncogenic potential.

Conclusions:

  • BCL-2 is a significant oncoprotein with multifaceted roles in cell death and survival.
  • Its dysregulation is implicated in various pathological conditions, particularly cancer.
  • Targeting BCL-2 offers potential therapeutic strategies.